You searched for "procedures"

4121 results found

Orbis teams up with the Alcon Foundation and OMEGA to improve eyecare in Zambia

The Orbis Flying Eye Hospital returns to Zambia for a three-week training project in Lusaka coinciding with World Sight Day on October 12.

Immunoglobulin G4-related ophthalmic disease – what is it? (Part 1)

Part 1: Epidemiology, classification, radiology, histopathology and associations (see Part 2 here) In this two-part series, Li Yen Goh reviews IgG4 disease and reminds us of diagnostic challenges faced. Introduction Immunoglobulin G4 (IgG4) disease is a recently recognised idiopathic systemic...

Pupils at a South Lanarkshire school experienced the challenges voters with sight loss face when casting their ballots

The mock election, which was held at Uddingston Grammar School on Friday 24 November, was organised by RNIB Scotland, in collaboration with South Lanarkshire Council and Haggeye, RNIB Scotland's award-winning youth forum.

The Eyes Have It and World Eye Health Day - A Q&A with Marsha de Cordova

Westminster Eye Health Day is the flagship parliamentary event of The Eyes have It, a partnership of Roche, Macular Society, Fight for Sight, The Royal College of Ophthalmologists, Association of Optometrists and RNIB and has returned for its third year, sponsored by Marsha de Cordova MP.

Falkirk girl with sight loss is World Book Day winner

Grace Kidd, 9, from Falkirk, is the winner of a creative writing competition hosted for the first time by leading sight loss charity, RNIB, to mark World Book Day.

The International AMD Genomics Consortium study: another success in understanding the complex genetics of AMD

Age-related macular degeneration (AMD) is a neurodegenerative complex disease of the eye and a major cause of blindness and visual impairment among the elderly worldwide. The early stages of the disease are characterised by asymptomatic pigmentary abnormalities and accumulation of...

Breakthroughs in the genetics of angle-closure glaucoma

Angle closure glaucoma (ACG) is not widely known to be a familial condition, yet the recent explosion of genetic data and large scale genome wide investigations have confirmed at least 13 genetic loci associated with ACG [1], and provided some...

Strategies for managing neovascular AMD and DMO in routine clinical care

Treatment practice in the management of neovascular age-related macular degeneration (AMD) and diabetic macular oedema (DMO) illustrate increasing adoption of patient-tailored treatment approaches based on initial diagnosis and regular monitoring of imaging and visual outcomes in routine clinical care. The...

Genetic profiling for personalised healthcare solutions in AMD – an update

Age-related macular degeneration (AMD) is a multifactorial condition influenced by genetics and lifestyle factors (Table 1). This article outlines several recent advances in AMD genetics, as well as evolving therapeutic concepts and established practical measures for the treatment and /...

Contemporary glaucoma therapy: spoilt for choice

The goal of glaucoma management is to prevent visual loss and disease progression in the patient’s lifetime through effective lowering of intraocular pressure (IOP), the primary modifiable risk factor in glaucoma. Sustained and consistent IOP reduction is key to halting...

NICE drugs: an update on what’s good to go

Treatment options recommended by the National Institute for Health and Care Excellence (NICE) must be readily available for use in the NHS of England and Wales. This article provides an overview of recent guidance from NICE and summary advice issued...

SILMO 2019: Anything goes, but sustainability grows

Trying to spot the trends at this year’s SILMO in Paris, one of the largest optical fairs in the world, was a tough ask. Thin metals, especially in rose gold, abounded, but that’s now; tomorrow remained elusive.